PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
108 hedge funds and large institutions have $148M invested in Paratek Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+8
Holders Change %
+8%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
25
Increased
33
Reduced
30
Closed
15
Calls
$2.11M
Puts
$1.21M
Net Calls
+$898K
Net Calls Change
-$914K
Top Buyers
| 1 |
1
BlackRock
New York
|
$21.6M |
| 2 |
2
Two Sigma Advisers
New York
|
$2.31M |
| 3 |
3
Renaissance Technologies
New York
|
$4.77M |
| 4 |
EI
4
EAM Investors
Solana Beach,
California
|
$1.07M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$13.9M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$684K |
| 2 |
2
D.E. Shaw & Co
New York
|
$2.48M |
| 3 |
WIC
3
Water Island Capital
New York
|
$494K |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$0 |
| 5 |
GIM
5
Granahan Investment Management
Waltham,
Massachusetts
|
$3.61M |
